• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸部高分辨率 CT 在纤维化性间质性肺疾病诊断评估中的重要性。

Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases.

机构信息

. Multimagem Diagnósticos e Hospital Órion, Goiânia (GO) Brasil.

. Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Goiás, Goiânia (GO) Brasil.

出版信息

J Bras Pneumol. 2021 May 31;47(3):e20200096. doi: 10.36416/1806-3756/e20200096. eCollection 2021.

DOI:10.36416/1806-3756/e20200096
PMID:34076172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8332714/
Abstract

Many conditions result in chronic interstitial lung disease (ILD), being classified as fibrosing ILDs, including idiopathic pulmonary fibrosis, connective tissue diseases, sarcoidosis, and fibrotic hypersensitivity pneumonitis. HRCT plays an important role in the clinical evaluation of fibrosing ILDs. Current treatment perspectives are encouraging and reinforce the need for HRCT scans of adequate technical quality for early detection of fibrosing ILD. Despite efforts in this regard, the significance and management of imaging findings of early interstitial lung abnormalities have yet to be clarified. After identification of CT findings consistent with fibrosing ILD, radiologists must be able to identify characteristic morphological patterns and, in some cases, features of specific clinical entities. In cases in which HRCT features are not sufficiently specific for a definitive diagnosis, HRCT can aid in selecting the best site for surgical lung biopsy. CT follow-up is useful for identifying progressive fibrosing ILDs and detecting complications unrelated to the underlying disease, including infections, acute exacerbations, and neoplasms. Automated quantification tools have clinical applicability and are likely to be available for use in imaging analysis in the near future. In addition, incorporation of CT evaluation into scoring systems based on clinical and functional parameters for staging fibrosing disease is likely to become valuable in determining prognosis. Knowledge of the clinical applications of CT evaluation is essential for specialists managing patients with fibrosing ILD and can have a positive impact on the clinical course of the disease.

摘要

许多疾病都会导致慢性间质性肺病(ILD),包括特发性肺纤维化、结缔组织疾病、结节病和纤维性过敏性肺炎等,这些疾病被归类为纤维性ILD。高分辨率 CT(HRCT)在纤维性ILD 的临床评估中发挥着重要作用。目前的治疗观点令人鼓舞,这进一步强调了需要进行具有足够技术质量的 HRCT 扫描,以便早期发现纤维性 ILD。尽管在这方面做出了努力,但早期肺间质异常的影像学表现的意义和管理仍有待阐明。在识别出与纤维性 ILD 一致的 CT 表现后,放射科医生必须能够识别出特征性的形态模式,在某些情况下,还需要识别出特定临床实体的特征。在 HRCT 特征不足以明确诊断的情况下,HRCT 可以帮助选择进行外科肺活检的最佳部位。CT 随访有助于识别进行性纤维性 ILD,并检测与基础疾病无关的并发症,包括感染、急性加重和肿瘤。自动量化工具具有临床适用性,并且可能在不久的将来可用于影像学分析。此外,将 CT 评估纳入基于临床和功能参数的纤维性疾病分期评分系统中,可能有助于确定预后。了解 CT 评估的临床应用对于管理纤维性 ILD 患者的专家至关重要,并且可以对疾病的临床过程产生积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/0db07ef61a5b/1806-3756-jbpneu-47-03-e20200096-gf8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/d7750ad5e3a0/1806-3756-jbpneu-47-03-e20200096-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/273527cca877/1806-3756-jbpneu-47-03-e20200096-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/49740440e43a/1806-3756-jbpneu-47-03-e20200096-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/da872c4339cc/1806-3756-jbpneu-47-03-e20200096-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/3bd4083b68e8/1806-3756-jbpneu-47-03-e20200096-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/a6cbe3f5eb52/1806-3756-jbpneu-47-03-e20200096-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/b48d67a8d3bf/1806-3756-jbpneu-47-03-e20200096-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/0db07ef61a5b/1806-3756-jbpneu-47-03-e20200096-gf8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/d7750ad5e3a0/1806-3756-jbpneu-47-03-e20200096-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/273527cca877/1806-3756-jbpneu-47-03-e20200096-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/49740440e43a/1806-3756-jbpneu-47-03-e20200096-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/da872c4339cc/1806-3756-jbpneu-47-03-e20200096-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/3bd4083b68e8/1806-3756-jbpneu-47-03-e20200096-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/a6cbe3f5eb52/1806-3756-jbpneu-47-03-e20200096-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/b48d67a8d3bf/1806-3756-jbpneu-47-03-e20200096-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c41/8332714/0db07ef61a5b/1806-3756-jbpneu-47-03-e20200096-gf8.jpg

相似文献

1
Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases.胸部高分辨率 CT 在纤维化性间质性肺疾病诊断评估中的重要性。
J Bras Pneumol. 2021 May 31;47(3):e20200096. doi: 10.36416/1806-3756/e20200096. eCollection 2021.
2
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.尼达尼布治疗进行性肺纤维化间质性肺疾病患者- INBUILD 试验中按间质性肺疾病诊断的亚组分析:一项随机、双盲、安慰剂对照、平行组试验。
Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5.
3
The natural history of progressive fibrosing interstitial lung diseases.特发性肺纤维化等进行性纤维性间质性肺疾病自然史。
Respir Res. 2019 Mar 14;20(1):57. doi: 10.1186/s12931-019-1022-1.
4
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
5
Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease type.按潜在间质性肺疾病类型划分的进展性肺纤维化疾病的医疗费用和利用情况。
J Manag Care Spec Pharm. 2024 Feb 3;30(2):163-174. doi: 10.18553/jmcp.2024.30.2.163.
6
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.在美国大型理赔数据库分析中估计的具有进行性表型的慢性纤维性间质性肺疾病的患病率和发病率。
Adv Ther. 2021 Jul;38(7):4100-4114. doi: 10.1007/s12325-021-01786-8. Epub 2021 Jun 17.
7
Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype.具有进行性表型的慢性纤维化间质性肺疾病(ILD)患者的护理模式。
BMC Pulm Med. 2022 Apr 23;22(1):153. doi: 10.1186/s12890-022-01953-9.
8
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.进行性纤维性间质性肺疾病:尼达尼布的新概念和适应证。
Mod Rheumatol. 2021 Jan;31(1):13-19. doi: 10.1080/14397595.2020.1826665.
9
Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification.纤维化性间质性肺疾病高分辨率 CT 扫描表现及更新分类的影像学综述
Chest. 2024 Apr;165(4):908-923. doi: 10.1016/j.chest.2023.11.037. Epub 2024 Jan 1.
10
Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.进行性纤维性间质性肺病:在两个意大利转诊中心的患病率和特征。
Respiration. 2020;99(10):838-845. doi: 10.1159/000509556. Epub 2020 Dec 2.

引用本文的文献

1
Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review.进行性肺纤维化的流行病学与预后:文献综述
Pulm Ther. 2025 Jun 16. doi: 10.1007/s41030-025-00302-5.
2
Quantification of progressive pulmonary fibrosis by visual scoring of HRCT images: recommendations from Italian chest radiology experts.通过对高分辨率计算机断层扫描(HRCT)图像进行视觉评分对进行性肺纤维化进行定量分析:来自意大利胸部放射学专家的建议。
Radiol Med. 2025 Jun;130(6):965-977. doi: 10.1007/s11547-025-01985-1. Epub 2025 Apr 7.
3
Spatial lung imaging in clinical and translational settings.

本文引用的文献

1
Predicting Outcome in Idiopathic Pulmonary Fibrosis: Addition of Fibrotic Score at Thin-Section CT of the Chest to Gender, Age, and Physiology Score Improves the Prediction Model.特发性肺纤维化的预后预测:将胸部薄层CT的纤维化评分加入性别、年龄和生理学评分可改善预测模型。
Radiol Cardiothorac Imaging. 2019 Jun 27;1(2):e180029. doi: 10.1148/ryct.2019180029. eCollection 2019 Jun.
2
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.成人过敏性肺炎的诊断。美国胸科学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
3
临床和转化环境中的肺部空间成像。
Breathe (Sheff). 2024 Oct 1;20(3):230224. doi: 10.1183/20734735.0224-2023. eCollection 2024 Oct.
4
The radiologist's role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review.放射科医生在检测全身抗癌治疗相关间质性肺疾病中的作用:一项教育性综述。
Insights Imaging. 2024 Aug 1;15(1):191. doi: 10.1186/s13244-024-01771-z.
5
Imaging in the diagnosis and management of fibrosing interstitial lung diseases.纤维化间质性肺疾病诊断与管理中的影像学检查
Breathe (Sheff). 2024 Mar;20(1):240006. doi: 10.1183/20734735.0006-2024. Epub 2024 May 14.
6
Radiologic approach and progressive exploration of connective tissue disease-related interstitial lung disease: meeting the curiosity of rheumatologists.结缔组织病相关间质性肺疾病的放射学方法及逐步探索:满足风湿病学家的好奇心
J Rheum Dis. 2024 Jan 1;31(1):3-14. doi: 10.4078/jrd.2023.0042. Epub 2023 Oct 18.
7
Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases.在纤维化疾病中,定量高分辨率计算机断层扫描指标与肺功能变化之间的相关性较弱或无相关性。
ERJ Open Res. 2023 Oct 2;9(5). doi: 10.1183/23120541.00210-2023. eCollection 2023 Sep.
8
Progressive pulmonary fibrosis: an expert group consensus statement.进行性肺纤维化:专家组共识声明。
Eur Respir J. 2023 Mar 30;61(3). doi: 10.1183/13993003.03187-2021. Print 2023 Mar.
9
Enhancing Imagistic Interstitial Lung Disease Diagnosis by Using Complex Networks.利用复杂网络增强间质性肺病的影像学诊断
Medicina (Kaunas). 2022 Sep 16;58(9):1288. doi: 10.3390/medicina58091288.
10
Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.气道巨噬细胞中胶原 1a1 的表达增加与纤维化 ILD 有关,并与 FVC 下降和死亡率增加相关。
Front Immunol. 2021 Nov 17;12:645548. doi: 10.3389/fimmu.2021.645548. eCollection 2021.
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.
偶然在 CT 上发现的肺间质异常:弗勒施纳学会的立场文件。
Lancet Respir Med. 2020 Jul;8(7):726-737. doi: 10.1016/S2213-2600(20)30168-5.
4
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
5
The 2018 Diagnosis of Idiopathic Pulmonary Fibrosis Guidelines: Surgical Lung Biopsy for Radiological Pattern of Probable Usual Interstitial Pneumonia Is Not Mandatory.《2018年特发性肺纤维化诊断指南》:对于可能为普通型间质性肺炎的放射学表现,并非必须进行外科肺活检。
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1089-1092. doi: 10.1164/rccm.201907-1324ED.
6
Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.胸膜肺弹力纤维增生症。临床、放射学和病理学特征的综述。
Ann Am Thorac Soc. 2019 Nov;16(11):1351-1359. doi: 10.1513/AnnalsATS.201902-181CME.
7
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis.马赛克衰减在鉴别纤维化型过敏性肺炎与特发性肺纤维化中的可变效用。
Eur Respir J. 2019 Jul 25;54(1). doi: 10.1183/13993003.00531-2019. Print 2019 Jul.
8
Fibrosing interstitial lung diseases: knowns and unknowns.纤维性间质性肺疾病:已知与未知。
Eur Respir Rev. 2019 Feb 27;28(151). doi: 10.1183/16000617.0100-2018. Print 2019 Mar 31.
9
Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis.间质肺异常:在向进展性肺纤维化迈进的道路上设置障碍。
Thorax. 2019 May;74(5):506-511. doi: 10.1136/thoraxjnl-2018-212446. Epub 2019 Feb 5.
10
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.影像学模式与间质性肺异常进展和死亡率相关。
Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC.